NEW YORK, April 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Lab USA, Inc ("Rocket Lab" or the "Company") (NASDAQ: RKLB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

LOS ANGELES, April 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Rocket Lab USA, Inc.  ("Rocket Lab" or "the Company") (NASDAQ: RKLB) for violations of the federal securities laws.

Shareholders who purchased the Company's securities between November 12, 2024 and February 25, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 28, 2025.           

LOS ANGELES, April 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rocket Lab USA, Inc. ("Rocket Lab" or "the Company") (NASDAQ: RKLB) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, April 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB).

Shareholders who purchased shares of RKLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Rocket Lab To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 in Rocket Lab between November 12, 2024 and February 25,  2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, April 27, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) and reminds investors of the April 28, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

NEW YORK, April 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025, both dates inclusive (the "Class Period"), of the important April 28, 2025 lead plaintiff deadline.

So what: If you purchased Rocket Lab securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, April 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket Lab investors who were adversely affected by alleged securities fraud between November 12, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team:

SAN DIEGO, April 25, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Lab USA, Inc. (NASDAQ: RKLB) securities between November 12, 2024 and February 25, 2025, all dates inclusive (the "Class Period"), have until this upcoming Monday, April 28, 2025 to seek appointment as lead plaintiff of the Rocket Lab class action lawsuit. Captioned Bray v. Rocket Lab USA, Inc., No. 25-cv-01733 (C.D. Cal.), the Rocket Lab class action lawsuit charges Rocket Lab as well as certain of Rocket Lab's top executives with violations of the Securities Exchange Act of 1934.

BENSALEM, Pa., April 24, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ROCKET LAB USA, INC. (RKLB), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 28, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB).

Shareholders who purchased shares of RKLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

NEW YORK, April 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Lab USA, Inc ("Rocket Lab" or the "Company") (NASDAQ: RKLB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

PHILADELPHIA, April 22, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) on behalf of purchasers of Rocket Lab securities between November 12, 2024 through February 25, 2025, inclusive (the "Class Period").

Investor Deadline: Investors who purchased or acquired ROCKET LAB securities during the Class Period may, no later than APRIL 28, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

SAN DIEGO, April 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Lab USA, Inc. (NASDAQ: RKLB) securities between November 12, 2024 and February 25, 2025, all dates inclusive (the "Class Period"), have until Monday, April 28, 2025 to seek appointment as lead plaintiff of the Rocket Lab class action lawsuit. Captioned Bray v. Rocket Lab USA, Inc., No. 25-cv-01733 (C.D. Cal.), the Rocket Lab class action lawsuit charges Rocket Lab as well as certain of Rocket Lab's top executives with violations of the Securities Exchange Act of 1934.

NEW YORK, April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket Lab investors who were adversely affected by alleged securities fraud between November 12, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team:

NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB).

Shareholders who purchased shares of RKLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

NEW YORK, April 20, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025, both dates inclusive (the "Class Period"), of the important April 28, 2025 lead plaintiff deadline.

So what: If you purchased Rocket Lab securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

LOS ANGELES, April 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ROCKET LAB USA, INC. (RKLB), CLICK HERE BEFORE APRIL 28, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

NEW YORK, April 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket Lab investors who were adversely affected by alleged securities fraud between November 12, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rocket Lab To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Rocket Lab between November 12, 2024 and February 25, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, April 17, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Lab USA, Inc. ("Rocket Lab" or the "Company") (NASDAQ: RKLB) and reminds investors of the April 28, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

NEW YORK, April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rocket Lab USA, Inc. (NASDAQ: RKLB).

Shareholders who purchased shares of RKLB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE: